Search

Author/Creator Adolfo, Vubil

1. Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial. Issue 6 (June 2021)

Authors:
De Castro, Nathalie; Marcy, Olivier; Chazallon, Corine; Messou, Eugène; Eholié, Serge; N'takpe, Jean-Baptiste; Bhatt, Nilesh; Khosa, Celso; Timana Massango, Isabel; Laureillard, Didier; Chau, Giang Do; Domergue, Anaïs; Veloso, Valdilea; Escada, Rodrigo; Wagner Cardoso, Sandra; Delaugerre, Constan...
Journal:
Lancet infectious diseases
Issue:
Volume 21:Issue 6(2021)
Page Start:
813
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search